by VH102021 | Nov 18, 2022 | News&events
Important recognition for Vismederi, which has ranked 72nd in the “Champions of Growth 2023” ranking list compiled by the German Institute for Quality and Finance (Itqf) and Repubblica’s “Affari e Finanza.” This is an important result...
by VH102021 | Sep 13, 2022 | News&events
VisMederi Pharma Srl and its new line of supplements have been officially presented this evening at the Volte di Vicobello location in Siena, in front of a large audience made up of local pharmacists and doctors operating on the territory. “I am really proud...
by VH102021 | Jun 1, 2022 | News&events
This morning at the Auditorium of the Toscana Life Sciences Foundation, the company ETHS Srl, part of the VisMederi Group, received a visit from the students of Kent State University (USA) taking part in the “Florence Health Institute” (FHI) Program,...
by cpellegrino | May 22, 2022 | News&events
The VisMederi Group keeps growing: its companies closed 2021 budgets with turnovers of over 25 million Euros. This represents an important result, closing a year still deeply affected by Covid-19 and vaccinations. Other significant numbers: 20% trading profit, 37% ROI...
by cpellegrino | May 17, 2022 | News&events
Important new developments for VisMederi Life Sciences. One of the exclusive tests promoted, related to the evaluation of the anti-SARS-CoV-2 activity of appropriately treated fabrics and surfaces, has now also obtained Accredia accreditation, according to ISO 17025...
by VH102021 | Mar 9, 2022 | News&events
VisMederi Srl took part into research on antibody and cellular response induced by mRna vaccine against Covid-19. This trial involved a group of 352 healthcare workers, 180 days after the second shot of Pfizer-Biontech mRna vaccine. VisMederi founder and CSO Emanuele...
